Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Exalenz Bioscience Ltd Announces Resignation of Chief Executive Officer, Mr. Steven Eitan

Wednesday, 21 Nov 2012 07:00pm EST 

Exalenz Bioscience Ltd announced that its Chief Executive Officer, Mr. Steven Eitan, will resign from the Company, effective from March 31, 2013. 

Company Quote

-0.1 -0.91%
29 Sep 2014